CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.


By BY CARL ZIMMER from NYT Health https://ift.tt/2S4aRhB

Comments

Popular posts from this blog

They’re Healthy. They’re Sustainable. So Why Don’t Humans Eat More Bugs?

A Climate Change-Induced Landslide Is Wreaking Havoc on Denali National Park